Skip to content
Pass Duke Elder
Textbook / Chapter 14 / Ocular pathology, genetics and systemic associations

Intraocular tumours: melanoma, retinoblastoma and metastases

Three tumours account for most exam questions on cancer inside the eye: uveal melanoma in adults, retinoblastoma in children, and metastases from breast and lung. This lesson explains how to tell a harmless choroidal naevus from a melanoma, what each tumour looks like down the microscope, how each spreads and why, and how they are treated in outline. It ends with a short account of lymphoma and of conjunctival tumours.

10 minute read4 linked questions

The choroidal naevus

The uvea (iris, ciliary body and choroid) is full of melanocytes, the pigment cells that also populate the skin. A choroidal naevus is a benign cluster of these cells, the equivalent of a mole. Naevi are common: about 5% of white adults have one, and they are much less frequent in people with darker skin. A typical naevus is a flat or barely raised grey-brown patch, no more than 2 mm thick, that causes no symptoms and is found by chance.

The clinical problem is that a small melanoma looks much the same. A naevus very rarely becomes malignant, roughly 1 in 5,000 to 1 in 8,800, but because naevi are so common, the question of whether a given pigmented lesion is a naevus or an early melanoma comes up constantly. Signs that a lesion has been present and quiet for years are reassuring. Drusen on its surface and atrophy of the overlying retinal pigment epithelium take years to form, so they indicate chronicity. A pale halo around the lesion also suggests stability.

Features that suggest melanoma

A set of risk features predicts which small pigmented lesions will grow. They are remembered with the phrase To Find Small Ocular Melanoma Using Helpful Hints Daily. Each feature has a reason behind it.

  • Thickness over 2 mm: a naevus is flat because its cells are not multiplying.
  • Fluid under the retina: an active tumour disturbs the retinal pigment epithelium, which then leaks.
  • Symptoms such as flashes, floaters or blurring, caused by that fluid or by the mass itself.
  • Orange pigment on the surface. This is lipofuscin, a waste pigment that collects in distressed retinal pigment epithelium over a metabolically active tumour.
  • Margin within 3 mm of the optic disc.
  • Ultrasound hollowness: the tumour interior is dark on scanning.
  • Halo absent.
  • Drusen absent, meaning there is no evidence of chronicity.

In the study behind the phrase, a lesion with none of these features had about a 3% chance of growing over five years. One feature raised this to about 38%, and two or more to over 50%. Lesions with no features are photographed and watched. Documented growth over a short period, less than two years, strongly suggests melanoma.

NaevusMelanoma
Thickness2 mm or less, usually flatMore than 2 mm, dome shaped
SurfaceDrusen, pigment epithelial atrophyOrange pigment (lipofuscin)
Subretinal fluidAbsentOften present
SymptomsNoneFlashes, floaters, blurred vision
Over timeStableGrows
Choroidal naevus and small melanoma compared

Uveal melanoma

Uveal melanoma is the most common primary intraocular malignancy in adults, with an incidence of about 5 per million per year. About 90% arise in the choroid, 7% in the ciliary body and 2% in the iris. Risk is highest in people with fair skin, light irises and northern European ancestry.

A choroidal melanoma is an elevated, dome shaped, grey-brown mass. Bruch membrane lies over it like a tight lid. In about one in five tumours the membrane ruptures and the tumour herniates through the hole, giving the characteristic mushroom or collar stud shape. Fluid leaks under the retina and can cause an exudative retinal detachment. On ultrasound the mass has low to medium internal reflectivity and looks hollow.

Histologically the tumour cells are of two kinds. Spindle cells are slender and elongated. Epithelioid cells are larger and rounder, and the more of them a tumour contains the higher the risk of metastasis. Many tumours are mixed. Spindle cell tumours therefore have the best outlook, mixed tumours an intermediate one and epithelioid tumours the worst: in one large series of enucleated eyes, 15 year mortality was about 19% for the most favourable spindle type and 72% for epithelioid tumours. Genetic testing of the tumour now predicts outcome better than cell type. Mutations in GNAQ or GNA11 are found in most tumours and are early events. Loss of one copy of chromosome 3 (monosomy 3) and inactivation of the BAP1 gene, which sits on chromosome 3, mark the tumours that metastasise.

The route of spread follows from anatomy. The uveal tract has no lymphatic channels, so a uveal melanoma cannot reach lymph nodes. It spreads by direct extension through the sclera and, above all, through the blood. The liver is involved in about 90% of patients who develop metastases, and is usually the first site. Roughly a quarter of patients have metastases by five years and nearly half do eventually, sometimes many years after the eye was treated successfully.

Treatment of the eye aims to destroy the tumour while keeping the globe where possible.

  • Plaque brachytherapy: a small radioactive disc (ruthenium-106 or iodine-125) is stitched to the sclera over the tumour for a few days. This is the usual treatment for small and medium tumours.
  • Proton beam radiotherapy: for larger tumours or those a plaque cannot reach.
  • Enucleation (removal of the eye): for very large tumours, optic nerve invasion or a blind painful eye.

The Collaborative Ocular Melanoma Study randomised more than 1,300 patients with medium tumours to enucleation or iodine-125 plaque. Five year survival was the same, 81% and 82%. Removing the eye does not improve survival, which is why eye-conserving treatment is standard. Metastatic disease responds poorly to chemotherapy. Tebentafusp, an immunotherapy that works only in patients with the tissue type HLA-A*02:01, improved one year survival in a phase 3 trial.

Retinoblastoma pathology

Retinoblastoma is the most common intraocular malignancy of childhood, with most cases diagnosed before the age of four. It arises from immature retinal cells that have lost both working copies of RB1, a tumour suppressor gene on chromosome 13q14 whose protein holds the cell cycle in check. About 60% of cases are unilateral and 40% bilateral. Bilateral cases are assumed to carry a germline mutation, as do about 15% of unilateral cases. The two-hit explanation and the inheritance are taught in the genetics lesson of this chapter, and the clinical presentation with leukocoria in the paediatric chapter.

Under the microscope the tumour is a sheet of small round blue cells: they have large dark nuclei and almost no cytoplasm, so haematoxylin dominates. The tumour outgrows its blood supply, so necrosis is very common, and calcification within the tumour is common too. Calcification in an intraocular mass in a young child is a strong pointer to retinoblastoma on imaging.

Better differentiated tumours arrange their cells in patterns that show what they are trying to become:

  • Flexner-Wintersteiner rosettes: a ring of cells around an empty central lumen. They are characteristic of retinoblastoma, though not needed for the diagnosis.
  • Homer Wright rosettes: cells around a central tangle of fibres with no lumen. These are less specific and are also seen in other neural tumours.
  • Fleurettes: bouquet-like groups showing the greatest photoreceptor differentiation.

The tumour grows in two directions. Endophytic growth is inwards into the vitreous, where seeds of tumour float free. Exophytic growth is outwards under the retina, causing a detachment. It leaves the eye along the optic nerve towards the brain, or through the choroid into the blood, reaching bone, liver and brain. When an eye is enucleated the pathologist reports the high risk features that call for adjuvant chemotherapy: invasion of the optic nerve beyond the lamina cribrosa, massive choroidal invasion, scleral invasion and anterior chamber involvement.

Children with a germline RB1 mutation carry it in every cell. They are at risk of a midline brain tumour (pinealoblastoma) with bilateral eye disease, called trilateral retinoblastoma, and of second cancers later in life, most often osteosarcoma. Treatment priorities run in the order life, then eye, then vision, using chemotherapy by vein or directly into the ophthalmic artery, with laser or cryotherapy, and enucleation for advanced eyes.

Metastases to the choroid

Tumour cells from elsewhere arrive by the blood, so they lodge in the most vascular part of the eye. Nearly 90% of uveal metastases are in the choroid. In women the usual primary is breast cancer, which accounted for about two thirds of cases in one large series. In men it is lung cancer. The eye lesion can be the first sign of the cancer: in the same series no primary was known at presentation in 29% of men and 12% of women. Secondary tumours are generally taught to be more common than any primary tumour inside the adult eye, but no figure was confirmed for this lesson, which is why the word primary matters in the statement about melanoma.

A choroidal metastasis is typically a creamy yellow, flat plateau with subretinal fluid out of proportion to its size. There may be several, and they may be in both eyes. On ultrasound the internal reflectivity is moderate to high. Treatment is that of the underlying cancer, with radiotherapy to the eye when vision is threatened.

MelanomaMetastasis
ColourGrey-brown, with orange pigmentCreamy yellow
ShapeDome or collar studFlat plateau
NumberSingle, one eyeMay be multiple and bilateral
Ultrasound reflectivityLow to mediumModerate to high
Direction of spreadFrom the eye to the liverTo the eye from breast or lung
Choroidal melanoma and choroidal metastasis compared

Lymphoma and conjunctival tumours in brief

Primary vitreoretinal lymphoma is a B cell lymphoma of the retina and vitreous that is closely linked to lymphoma of the brain. It presents in older adults as a chronic uveitis that does not behave, and is diagnosed by vitreous biopsy. It is covered with the masquerade syndromes in the uveitis chapter.

On the surface of the eye, ocular surface squamous neoplasia is a spectrum from dysplasia confined to the epithelium to invasive squamous cell carcinoma. It arises at the limbus in the sun-exposed interpalpebral zone as a gelatinous, papillary or white plaque-like lesion. Ultraviolet light is the main risk factor, and HIV infection and human papillomavirus are others. Treatment is excision with cryotherapy to the edges, or topical chemotherapy such as mitomycin C, 5-fluorouracil or interferon. Conjunctival melanoma is a different disease from uveal melanoma. Most cases arise from flat acquired pigmentation with atypical cells (primary acquired melanosis with atypia) and a minority from a naevus. Unlike the uvea, the conjunctiva has lymphatics, so sentinel lymph node biopsy is considered for thicker tumours. Eyelid tumours, led by basal cell carcinoma, are taught in the oculoplastics chapter.

Summary

  • A choroidal naevus is flat, 2 mm thick or less and symptomless; drusen on its surface indicate chronicity.
  • Thickness over 2 mm, subretinal fluid, symptoms, orange pigment and a margin near the disc are the main features that predict growth into melanoma.
  • Uveal melanoma is the most common primary intraocular malignancy in adults, and about 90% arise in the choroid.
  • A collar stud shape means the tumour has broken through Bruch membrane.
  • Epithelioid cells, monosomy 3 and BAP1 loss indicate a poor prognosis in uveal melanoma.
  • Uveal melanoma spreads through the blood to the liver because the uvea has no lymphatics.
  • Plaque brachytherapy gives the same survival as enucleation for medium tumours.
  • Retinoblastoma is a small round blue cell tumour with necrosis, calcification and Flexner-Wintersteiner rosettes, caused by loss of both copies of RB1 on 13q14.
  • Retinoblastoma leaves the eye along the optic nerve and through the choroid.
  • Choroidal metastases are creamy yellow, flat, often multiple and bilateral, and come from breast in women and lung in men.

Check yourself

Quick recall on this lesson. These are easier than the question bank.

1. To which organ does uveal melanoma most often metastasise?
2. Which histological feature is characteristic of retinoblastoma?
3. Which finding on a pigmented choroidal lesion suggests a long-standing benign naevus?
4. What is the most common primary site for a choroidal metastasis in a woman?
Practise 4 questions on this lesson

Written for revision. It is not a source of clinical advice, and guidance changes.